Eagle Pharmaceuticals and AMRI will together develop and manufacture several select and complex parenteral drug products for registration and commercialization in the U.S., which will expand Eagle’s portfolio of existing products and product candidates targeting therapeutic areas including oncology, critical care and orphan diseases. AMRI will develop and initially provide cGMP manufacturing and analytical support for the registration of the new product candidates. Eagle will be responsible f...